Breaking News, Promotions & Moves

Biogen Idec

Douglas E. Williams, Ph.D., has been named executive vice president of R&D at Biogen Idec and Steven H. Holtzman has been named executive vice president, corporate development.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Douglas E. Williams, Ph.D., has been named executive vice president of R&D at Biogen Idec and Steven H. Holtzman has been named executive vice president, corporate development. Dr. Williams will oversee the company’s global R&D operation, including discovery research, development, clinical operations and regulatory affairs. Mr. Holtzman will oversee corporate strategy, business development, portfolio management, program leadership and the New Ventures fund. Both will report to Biogen’s c...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters